Allevia Health, Inc. Secures $1

Allevia Health, Inc. has secured $100,000 in investment capital from private investors.

The company specializes in providing authorized sales and service for Alpha-Stim medical devices across Oregon and Washington.

Alpha-Stim devices are designed to treat anxiety, depression, insomnia, and pain, offering non-pharmacological options for patients and practitioners seeking alternatives to traditional medication.

These devices are backed by extensive research and clinical data, and are cleared by the FDA for distribution in the USA.

This funding round occurs amidst a growing demand for alternative treatments for mood and pain disorders.

With recent public discourse highlighting potential side effects of psychotropic and pain medications, an increasing number of medical practitioners and patients are actively seeking non-pharmacological solutions.

Allevia Health positions itself as a leader in increasing the utilization and access to Cranial Electrotherapy Stimulation (CES) and Microcurrent Electrical Therapy (MET) technology.

The company also offers continuing medical education seminars and inservices for practitioners interested in integrating these therapies into their clinical practice, underscoring its commitment to education and adoption.

Allevia Health, Inc. plans to deploy the newly raised capital to support its ongoing growth initiatives and expand its operational capabilities.

This investment is expected to strengthen the company's efforts to enhance service delivery to the patients and practitioners it serves, further solidifying its commitment to advancing access to CES and MET technology in the management of mood disorders and chronic pain.

The company aims to continue its leadership in this evolving healthcare sector, striving to improve patient outcomes through innovative treatment options.